A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer
NCT01808040
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Post Menopausal, Hormone Receptor Positive Breast Cancer
Interventions
DRUG:
TAK700
Sponsor
University of Wisconsin, Madison
Collaborators
[object Object]